Ugbomoiko Daniel Ohilebo

Sero-Prevalence and Immunological Profile of SARS-CoV-2 Antibodies in Nigerian Sickle Cell Disease Patients During the COVID-19 Pandemic

Amusan Festus Olatubosun, Ugbomoiko Daniel Ohilebo, Obhioze Augustine Akpoka, Adesina Beatrice Ebun, OniyeAdesolaHelen & Erameh Theophilus Ogie · Advances in Research · 2025

Introduction: Nigeria has the highest prevalence of sickle cell disease (SCD) globally, making it a major genetic disorder of public health concern in Africa. During the COVID-19 pandemic, SCD patients were particularly vulnerable due to their compromised immune and hematological...

Open access Research Article 10.9734/air/2025/v26i31352

Alterations in Cellular Immune Markers Among Patients with Type 2 Diabetes Mellitus Compared to Healthy Controls

Nwaobi Anthony Chukwuka, Ugbomoiko Daniel Ohilebo, Emokpae Mathias Abiodun, Erameh Theophilus Ogie, Ezekiel Dauda Gambo, Erifeta Georgina Omonegho, Osaiyuwu Omoruyi Felix & Omogiade Christabel · International Journal of Biochemistry Research & Review · 2025

Introduction: In addition to hyperglycemia, type 2 diabetes mellitus (T2DM) is a chronic metabolic disease marked by immunological dysregulation and low-grade systemic inflammation. Changes in cellular immune markers, including CD4⁺ and CD8⁺ T lymphocytes, have been identified as...

Open access Research Article 10.9734/ijbcrr/2025/v34i3999